LP 533401

CAS : 945976-43-2

Ref. 3D-VMB97643

Informations sur le produit

• Nom: LP 533401

Description

LP 533401 is a drug that has been shown to be effective in treating bowel disease. It has been used in treatment trials for metabolic disorders and has been shown to decrease hepatic steatosis, carcinoid syndrome, and inflammatory bowel disease. LP 533401 affects serotonin levels by inhibiting the production of serotonin from tryptophan and may also have a direct effect on serotonin receptors. This drug has been shown to have physiological effects such as systolic pressure, fetal bovine serum concentrations, and CD-1 mouse weight gain. The molecular docking analysis of this drug with serotonin receptor 1A (5HT1A) shows that it binds to the active site of the receptor and blocks its activity.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 526.48 g/mol
• Formule: C₂₇H₂₂F₄N₄O₃
• Degré de pureté: Min. 95%